Literature DB >> 24388223

Myasthenia gravis: predictive factors associated with the synchronized elevation of anti-acetylcholine receptor antibody titer in Kanazawa, Japan.

Kazuo Iwasa1, Hiroaki Yoshikawa2, Miharu Samuraki3, Moeko Shinohara3, Tsuyoshi Hamaguchi3, Kenjiro Ono3, Hiroyuki Nakamura4, Masahito Yamada3.   

Abstract

For a brief period, an increased incidence of elevated anti-acetylcholine receptor antibody titer was observed in patients with myasthenia gravis (MG) in Kanazawa, Japan. The purpose of this study was to examine the predictive factors associated with this antibody titer elevation. Decreased odds of titer elevation were seen in patients with early-onset MG than in those with late-onset MG. In patients with non-thymoma-related MG, thymectomy prevented the antibody titer elevation. Our data suggest that late-onset MG may have a different immunogenic response and the thymus might play an immunoregulatory role against extrinsic factors in some types of MG.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-acetylcholine receptor antibody; Autoimmunity; Myasthenia gravis; Predictive factor

Mesh:

Substances:

Year:  2013        PMID: 24388223     DOI: 10.1016/j.jneuroim.2013.12.011

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  2 in total

Review 1.  Ageing and myeloid-derived suppressor cells: possible involvement in immunosenescence and age-related disease.

Authors:  Valquiria Bueno; Osvaldo Augusto Sant'Anna; Janet M Lord
Journal:  Age (Dordr)       Date:  2014-11-16

2.  No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients.

Authors:  Lulu Wang; Shumin Wang; Haonan Yang; Jiaojiao Han; Xue Zhao; Sensen Han; Yingna Zhang; Jie Lv; Jing Zhang; Mingqiang Li; Ying Ji; Shuxian Zhou; Xiaoxiao He; Hua Fang; Junhong Yang; Yunke Zhang; Qingyong Zhang; Peiyang Gao; Feng Gao
Journal:  Brain Behav       Date:  2021-06-02       Impact factor: 2.708

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.